Firestein GS: Evolving concepts of rheumatoid arthritis. Nature. 2003, 423: 356-361. 10.1038/nature01661.
Article
CAS
PubMed
Google Scholar
Szekanecz Z, Koch AE: Mechanisms of disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol. 2007, 3: 635-643. 10.1038/ncprheum0647.
Article
CAS
PubMed
Google Scholar
Firestein GS: Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J Clin Invest. 1999, 103: 3-4. 10.1172/JCI5929.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lainer-Carr D, Brahn E: Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol. 2007, 3: 434-442.
Article
CAS
PubMed
Google Scholar
Ferrara N, Kerbel RS: Angiogenesis as a therapeutic target. Nature. 2005, 438: 967-974. 10.1038/nature04483.
Article
CAS
PubMed
Google Scholar
Folkman J: Angiogenesis: an organizing principle for drug discovery?. Nat Rev Drug Discov. 2007, 6: 273-286. 10.1038/nrd2115.
Article
CAS
PubMed
Google Scholar
Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L: VEGF receptor signalling in control of vascular function. Nat Rev Mol Cell Biol. 2006, 7: 359-371. 10.1038/nrm1911.
Article
CAS
PubMed
Google Scholar
Min JK, Kim YM, Kim YM, Kim EC, Gho YS, Kang IJ, Lee SY, Kong YY, Kwon YG: Vascular endothelial growth factor up-regulates expression of receptor activator of NF-κB (RANK) in endothelial cells: concomitant increase of angiogenic responses to rank ligand. J Biol Chem. 2003, 278: 39548-39557. 10.1074/jbc.M300539200.
Article
CAS
PubMed
Google Scholar
Loges S, Mazzone M, Hohensinner P, Carmeliet P: Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell. 2009, 15: 167-170. 10.1016/j.ccr.2009.02.007.
Article
CAS
PubMed
Google Scholar
Eskens FA, Verweij J: The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors: a review. Eur J Cancer. 2006, 42: 3127-3139. 10.1016/j.ejca.2006.09.015.
Article
CAS
PubMed
Google Scholar
Mancuso MR, Davis R, Norberg SM, O'Brien S, Sennino B, Nakahara T, Yao VJ, Inai T, Brooks P, Freimark B, Shalinsky DR, Hu-Lowe DD, McDonald DM: Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest. 2006, 116: 2610-2621. 10.1172/JCI24612.
Article
PubMed Central
CAS
PubMed
Google Scholar
Augustin HG, Koh GY, Thurston G, Alitalo K: Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009, 10: 165-177. 10.1038/nrm2639.
Article
CAS
PubMed
Google Scholar
Chen Y, Donnelly E, Kobayashi H, Debusk LM, Lin PC: Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. Arthritis Rheum. 2005, 52: 1585-1594. 10.1002/art.21016.
Article
CAS
PubMed
Google Scholar
Gravallese EM, Pettit AR, Lee R, Madore R, Manning C, Tsay A, Gaspar J, Goldring MB, Goldring SR, Oettgen P: Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor α. Ann Rheum Dis. 2003, 62: 100-107. 10.1136/ard.62.2.100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Raatz Y, Ibrahim S, Feldmann M, Paleolog EM: Gene expression profiling and functional analysis of angiogenic markers in murine collagen-induced arthritis. Arthritis Res Ther. 2012, 14: R169-10.1186/ar3922.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hashiramoto A, Sakai C, Yoshida K, Tsumiyama K, Miura Y, Shiozawa K, Nose M, Komai K, Shiozawa S: Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt. Arthritis Rheum. 2007, 56: 2170-2179. 10.1002/art.22727.
Article
CAS
PubMed
Google Scholar
Krausz S, Garcia S, Ambarus CA, de Launay D, Foster M, Naiman B, Iverson W, Connor JR, Sleeman MA, Coyle AJ, Hamann J, Baeten D, Tak PP, Reedquist KA: Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis. Ann Rheum Dis. 2012, 71: 1402-1410. 10.1136/annrheumdis-2011-200718.
Article
CAS
PubMed
Google Scholar
Jin P, Zhang J, Sumariwalla PF, Ni I, Jorgensen B, Crawford D, Phillips S, Feldmann M, Shepard HM, Paleolog EM: Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis. Arthritis Res Ther. 2008, 10: R73-10.1186/ar2447.
Article
PubMed Central
PubMed
Google Scholar
DeBusk LM, Chen Y, Nishishita T, Chen J, Thomas JW, Lin PC: Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor α-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2461-2471. 10.1002/art.11213.
Article
CAS
PubMed
Google Scholar
Hashizume H, Falcón BL, Kuroda T, Baluk P, Coxon A, Yu D, Bready JV, Oliner JD, McDonald DM: Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth. Cancer Res. 2010, 70: 2213-2223. 10.1158/0008-5472.CAN-09-1977.
Article
PubMed Central
CAS
PubMed
Google Scholar
Oliner J, Min H, Leal J, Yu D, Rao S, You E, Tang X, Kim H, Meyer S, Han SJ, Hawkins N, Rosenfeld R, Davy E, Graham K, Jacobsen F, Stevenson S, Ho J, Chen Q, Hartmann T, Michaels M, Kelley M, Li L, Sitney K, Martin F, Sun JR, Zhang N, Lu J, Estrada J, Kumar R, Coxon A, Kaufman S, Pretorius J, Scully S, Cattley R, Payton M, Coats S, Nguyen L, Desilva B, Ndifor A, Hayward I, Radinsky R, Boone T, Kendall R: Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell. 2004, 6: 507-516. 10.1016/j.ccr.2004.09.030.
Article
CAS
PubMed
Google Scholar
Koh YJ, Kim HZ, Hwang SI, Lee JE, Oh N, Jung K, Kim M, Kim KE, Kim H, Lim NK, Jeon CJ, Lee GM, Jeon BH, Nam DH, Sung HK, Nagy A, Yoo OJ, Koh GY: Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage. Cancer Cell. 2010, 18: 171-184. 10.1016/j.ccr.2010.07.001.
Article
CAS
PubMed
Google Scholar
Hah YS, Lee YR, Jun JS, Lim HS, Kim HO, Jeong YG, Hur GM, Lee SY, Chung MJ, Park JW, Lee SI, Park BH: A20 suppresses inflammatory responses and bone destruction in fibroblast-like synoviocytes and collagen-induced arthritic mice. Arthritis Rheum. 2010, 62: 2313-2321. 10.1002/art.27545.
Article
CAS
PubMed
Google Scholar
Lu J, Kasama T, Kobayashi K, Yoda Y, Shiozawa F, Hanyuda M, Negishi M, Ide H, Adachi M: Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol. 2000, 164: 5922-5927.
Article
CAS
PubMed
Google Scholar
Malik NM, Jin P, Raatz Y, Sumariwalla PF, Kiriakidis S, Shepard M, Feldmann M, Paleolog EM: Regulation of the angiopoietin-Tie ligand-receptor system with a novel splice variant of Tie1 reduces the severity of murine arthritis. Rheumatology (Oxford). 2010, 49: 1828-1839. 10.1093/rheumatology/keq163.
Article
CAS
Google Scholar
Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P: Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002, 8: 831-840.
CAS
PubMed
Google Scholar
Yoo SA, Joon HJ, Kim HS, Chae CB, De Falco S, Cho CS, Kim WU: Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum. 2009, 60: 345-354. 10.1002/art.24289.
Article
CAS
PubMed
Google Scholar
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG: Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation. Nat Med. 2006, 12: 235-239. 10.1038/nm1351.
Article
CAS
PubMed
Google Scholar
Matsumoto Y, Tanaka K, Hirata G, Hanada M, Matsuda S, Shuto T, Iwamoto Y: Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. J Immunol. 2002, 168: 5824-5831.
Article
CAS
PubMed
Google Scholar
Suzuki T, Miyamoto T, Fujita N, Ninomiya K, Iwasaki R, Toyama Y, Suda T: Osteoblast-specific Angiopoietin 1 overexpression increases bone mass. Biochem Biophys Res Commun. 2007, 362: 1019-1025. 10.1016/j.bbrc.2007.08.099.
Article
CAS
PubMed
Google Scholar
Jeong BC, Kim HJ, Bae IH, Lee KN, Lee KY, Oh WM, Kim SH, Kang IC, Lee SE, Koh GY, Kim KK, Koh JT: COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Bone. 2010, 46: 479-486. 10.1016/j.bone.2009.09.019.
Article
CAS
PubMed
Google Scholar
Bergers G, Hanahan D: Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008, 8: 592-603. 10.1038/nrc2442.
Article
PubMed Central
CAS
PubMed
Google Scholar
Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ: A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999, 340: 253-259. 10.1056/NEJM199901283400401.
Article
CAS
PubMed
Google Scholar
Taylor PC, Feldmann M: Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol. 2009, 5: 578-582. 10.1038/nrrheum.2009.181.
Article
CAS
PubMed
Google Scholar
Finckh A, Simard JF, Gabay C, Guerne PA, SCQM physicians: Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis. Ann Rheum Dis. 2006, 65: 746-752. 10.1136/ard.2005.045062.
Article
PubMed Central
CAS
PubMed
Google Scholar